Panel Discussion | Hot Topics in Antegrade Approach

Saturday, March 7, 2026

11:39 AM - 12:05 PM EST

Location: International Ballroom Center

Moderator(s)

Michael Megaly, MD

Interventional cardiologist
Integris Health Heart Hospital
Oklahoma City, Oklahoma, United States

Disclosure(s): No financial relationships to disclose
Stephane Rinfret, MD, SM

Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure(s): SIS Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

Disclosure(s): No financial relationships to disclose
Jeffrey W. Moses, MD, FSCAI

John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States

Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
Angela M. Taylor, MD, MS, MBA

Professor
University of Virginia
Charlottesville, Virginia, United States

Disclosure(s): Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Seung-Woon Rha, MD, PhD, FACC

Professor
Korea University Guro Hospital
Seoul, Republic of Korea

Disclosure(s): No financial relationships to disclose
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Gauravpal Singh Gill, MD

Interventional Cardiologist
James River Cardiology, Virginia, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Michael Megaly, MD: No financial relationships to disclose

Stephane Rinfret, MD, SM: SIS Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Lindsey Cilia, MD: No financial relationships to disclose

Jeffrey W. Moses, MD, FSCAI: Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)

Angela M. Taylor, MD, MS, MBA: Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Seung-Woon Rha, MD, PhD, FACC: No financial relationships to disclose

Masahisa Yamane, MD: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Gauravpal Singh Gill, MD: No financial relationships to disclose